gross profit bridgeinconsistent2025-03-31
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
Revenue
$613.23M
Fiscal year ended 2026-06-30Operating income
-$35.15M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30ACCENDRA HEALTH INC/VA/ (ACH) reported revenue of $613.23M and net income of -$89.07M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ACCENDRA HEALTH INC/VA/’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $613.23M | $627.78M | $708.97M | $697.26M | $681.92M | $673.88M | $695.02M | $686.85M | $660.40M | $2.61B |
| Cost of revenue | $349.83M | $349.75M | $385.71M | $375.07M | $357.32M | Unavailable | $362.03M | Unavailable | Unavailable | $2.08B |
| Gross profit | $263.41M | $278.03M | $323.26M | $322.20M | $324.60M | Unavailable | $579.77M | Unavailable | Unavailable | $535.53M |
| Operating income | -$35.15M | $17.12M | $20.91M | $26.47M | -$39.71M | $19.79M | -$272.70M | $31.08M | $16.92M | $9.70M |
| Net income | -$89.07M | -$6.47M | -$56.33M | -$150.28M | -$869.06M | -$24.98M | -$296.12M | -$12.77M | -$31.91M | -$21.89M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 76.70M | shares 76.43M | Unavailable | shares 77.29M | shares 76.94M | shares 77.27M | Unavailable | shares 78.48M | shares 76.73M | shares 76.32M |
| Pretax income | -$87.63M | -$16.25M | -$7.97M | -$3.64M | -$84.95M | -$5.40M | -$302.04M | $958.00K | -$9.48M | -$27.11M |
| Income tax expense | $1.44M | -$9.78M | $1.47M | $1.97M | -$1.13M | -$1.59M | $29.82M | -$303.00K | -$2.74M | -$5.23M |
| Diluted EPS | $-1.16 | $-0.08 | Unavailable | $-1.94 | $-11.30 | $-0.32 | Unavailable | $-0.16 | $-0.42 | $-0.29 |
| Selling, general & administrative | $243.56M | $255.23M | $271.50M | $265.84M | $267.85M | $262.37M | $269.89M | $272.32M | $269.92M | $477.61M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $7.65M | $336.88M | $281.99M | $32.84M | $38.26M | $59.44M | $27.57M | $45.45M | $243.67M | $244.87M |
| Total assets | $2.11B | $2.42B | $2.45B | $4.04B | $4.15B | $4.86B | $4.66B | $5.08B | $5.30B | $5.21B |
| Current assets | $271.45M | $588.50M | $547.87M | $2.13B | $2.30B | $2.21B | $2.02B | $2.12B | $2.33B | $2.24B |
| Total liabilities | $2.66B | $2.88B | $2.91B | $4.47B | $4.44B | $4.29B | $4.07B | $4.21B | $4.44B | $4.31B |
| Current liabilities | $666.22M | $1.20B | $947.08M | $2.47B | $2.67B | $1.96B | $1.85B | $1.93B | $2.13B | $1.93B |
| Total equity incl. NCI | -$550.94M | -$464.76M | -$460.98M | -$429.51M | -$281.01M | $570.98M | $586.36M | $895.73M | $881.84M | $916.01M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $73.34M | $65.28M | $74.44M | $63.85M | $69.23M | $1.41B | $67.58M | $1.24B | $1.23B | $1.14B |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $1.23B | $1.23B | $1.23B | $1.23B | $1.23B | $1.33B | $1.23B | $1.64B | $1.63B | $1.64B |
| Long-term debt | $1.72B | $1.52B | $1.80B | $1.84B | $1.59B | $1.90B | $1.80B | $1.84B | $1.87B | $1.95B |
| Accounts payable | $352.80M | $374.82M | $363.56M | $339.73M | $357.04M | $1.38B | $359.93M | $1.34B | $1.38B | $1.22B |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | Unavailable | Unavailable | Unavailable | -$172.52M | $37.61M | -$35.07M | $71.00M | $27.31M | $116.15M | -$52.96M |
| Capital expenditures | $47.59M | $41.65M | $13.13M | $74.41M | $57.62M | $45.79M | $22.26M | $57.65M | $44.38M | $46.00M |
| Investing cash flow | -$31.24M | $53.92M | $285.00M | -$39.46M | -$52.92M | -$48.20M | -$52.30M | -$27.19M | -$35.17M | -$1.87M |
| Financing cash flow | -$271.98M | $51.08M | -$117.50M | $181.10M | $31.70M | $92.78M | -$43.10M | -$199.59M | -$78.24M | $53.32M |
| Net change in cash | -$329.23M | $54.89M | $235.82M | -$30.92M | $17.65M | $10.05M | -$25.71M | -$198.38M | $2.68M | -$2.13M |
| Stock-based compensation | $4.00M | $3.09M | -$4.46M | $8.04M | $4.87M | $4.42M | -$2.64M | $5.68M | $6.74M | $6.87M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | $0 | $3.52M | $0 | $5.15M | $1.50M | Unavailable | $0 | $0 | $0 |
| Depreciation & amortization | $65.70M | $61.74M | $29.87M | $98.76M | $42.99M | $42.90M | -$18.31M | $61.61M | $63.88M | $74.10M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | -$246.93M | Unavailable | Unavailable | Unavailable | -$30.34M | $71.77M | Unavailable |
| Gross margin | 43.0% | 44.3% | 45.6% | 46.2% | 47.6% | Unavailable | Unavailable | Unavailable | Unavailable | 20.5% |
| Operating margin | -5.7% | 2.7% | 2.9% | 3.8% | -5.8% | 2.9% | -39.2% | 4.5% | 2.6% | 0.4% |
| FCF margin | Unavailable | Unavailable | Unavailable | -35.4% | Unavailable | Unavailable | Unavailable | -4.4% | 10.9% | Unavailable |
| SBC / revenue | 0.7% | 0.5% | -0.6% | 1.2% | 0.7% | 0.7% | -0.4% | 0.8% | 1.0% | 0.3% |
| Current ratio | 0.41x | 0.49x | 0.58x | 0.86x | 0.86x | 1.13x | 1.09x | 1.09x | 1.09x | 1.16x |
| Revenue YoY growth | -10.1% | -6.8% | 2.0% | 1.5% | 3.3% | -74.2% | Unavailable | -73.5% | -74.2% | 3.6% |
| Net margin | -14.5% | Unavailable | -7.9% | -21.6% | -127.4% | Unavailable | -42.6% | -1.9% | Unavailable | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 7.8% | 6.6% | 1.9% | 10.7% | 8.5% | 6.8% | 3.2% | 8.4% | 6.7% | Unavailable |
| Long-term debt / equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -31.6% | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-10View SEC filing
10-Q · Filed 2026-05-11View SEC filing
10-K · Filed 2026-02-20View SEC filing
10-Q · Filed 2025-10-31View SEC filing
10-Q · Filed 2025-08-11View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Companies in the same industry
Reconciliation checks needing review
8 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2024-09-30
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
gross profit bridgeinconsistent2024-06-30
Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.
balance equationreview2024-09-30
Difference 21138000 exceeds tolerance 5081282.000. Presentation or filing-vintage differences need review.
balance equationreview2024-06-30
Difference 21138000 exceeds tolerance 5304004.000. Presentation or filing-vintage differences need review.
balance equationreview2024-03-31
Difference 21138000 exceeds tolerance 5207993.000. Presentation or filing-vintage differences need review.
balance equationreview2023-12-31
Difference 21138000 exceeds tolerance 5093322.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 21138000 exceeds tolerance 5386283.000. Presentation or filing-vintage differences need review.